VitaDAO

VitaDAO, the decentralized longevity research DAO, has launched VitaApp, a health data tool that tracks biological age using AI-driven analysis. The app collects user health data to estimate biologica…

Tempus AI has agreed to acquire Personalis, Inc. for $1.5 billion, or $16.25 per share, gaining its NeXT Personal minimal residual disease blood test for cancer detection. The deal targets a $20 billi…